Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2017 11:14 ET | Source: Boston Therapeutics

Boston Therapeutics secures $1 Million financing for the first phase Multi-Centre International Ph II-III Trial

LAWRENCE, MA--(Marketwired - Apr 26, 2017) - Boston Therapeutics, Inc. (OTCQB: BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong, announced today the fully financed new...
February 07, 2017 07:51 ET | Source: Boston Therapeutics

Boston Therapeutics Business Update

LAWRENCE, MA--(Marketwired - Feb 7, 2017) - On February 1, 2017 Boston Therapeutics, Inc., headquartered in Lawrence MA, (OTCQB: BTHE) disclosed its restructured operations activity in a two...
October 13, 2016 10:16 ET | Source: Boston Therapeutics

Boston Therapeutics Announces Innovation Grant

LAWRENCE, MA--(Marketwired - Oct 13, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) - Today Boston Therapeutics and Advance Pharmaceutical Co., Ltd., which holds a license for the...
October 06, 2016 08:22 ET | Source: Boston Therapeutics

Boston Therapeutics Reports Positive Topline Data From Proof of Concept Asia Trial

LAWRENCE, MA--(Marketwired - Oct 6, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong presented today the positive topline data...
October 03, 2016 13:15 ET | Source: Boston Therapeutics

Boston Therapeutics Completes Private Offering, Appoints New CEO

LAWRENCE, MA--(Marketwired - Oct 3, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or the "Company") announced that it closed a private placement yielding gross proceeds to...
December 29, 2015 08:53 ET | Source: Boston Therapeutics

Boston Therapeutics' sugardown(R) in Clinical Trials Reduces Glucose, Fructose and Insulin

NEWTON, MA--(Marketwired - Dec 29, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) released final trial results from its proof of concept (POC) Sydney University study that showed consumption of...
November 20, 2015 16:57 ET | Source: Boston Therapeutics

Boston Therapeutics, Inc. Reports Third Quarter Results and Provides Corporate Update

NEWTON, MA--(Marketwired - Nov 20, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE), a leading developer of novel compounds based on complex carbohydrate chemistry for the treatment of metabolic...
October 06, 2015 07:00 ET | Source: Boston Therapeutics

Boston Therapeutics Completes Enrollment for BTI-320 Clinical Trial

MANCHESTER, NH--(Marketwired - Oct 6, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) today announced that its Hong Kong affiliate, Advance Pharmaceutical Company, Ltd. (APC), completed enrollment...
September 29, 2015 13:48 ET | Source: Boston Therapeutics

Boston Therapeutics Pays Off Convertible Promissory Notes

MANCHESTER, NH--(Marketwired - Sep 29, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) (the "Company") announced that on September 24, 2015, the Company paid in-full all of the Company's...
September 15, 2015 07:00 ET | Source: Boston Therapeutics

Boston Therapeutics' BTI-320 in Clinical Trial Significantly Reduces Both Glucose and Fructose Levels in Blood

MANCHESTER, NH--(Marketwired - Sep 15, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) today announced that its Hong Kong affiliate, Advance Pharmaceutical Company, Ltd. (APC), is conducting a...